Unum Group (NYSE:UNM) Position Raised by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. increased its position in shares of Unum Group (NYSE:UNM) by 31.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 296,960 shares of the financial services provider’s stock after purchasing an additional 70,482 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Unum Group were worth $21,687,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. KBC Group NV raised its holdings in Unum Group by 1,002.8% during the fourth quarter. KBC Group NV now owns 53,267 shares of the financial services provider’s stock worth $3,890,000 after purchasing an additional 48,437 shares in the last quarter. Blue Trust Inc. increased its holdings in shares of Unum Group by 44.1% in the fourth quarter. Blue Trust Inc. now owns 16,495 shares of the financial services provider’s stock valued at $1,205,000 after buying an additional 5,047 shares in the last quarter. PFG Investments LLC bought a new position in shares of Unum Group in the fourth quarter valued at $216,000. First Citizens Bank & Trust Co. increased its holdings in shares of Unum Group by 12.5% in the fourth quarter. First Citizens Bank & Trust Co. now owns 5,868 shares of the financial services provider’s stock valued at $429,000 after buying an additional 651 shares in the last quarter. Finally, Flagship Harbor Advisors LLC bought a new position in shares of Unum Group in the fourth quarter valued at $218,000. Institutional investors own 86.57% of the company’s stock.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Barclays upped their price target on Unum Group from $76.00 to $85.00 and gave the company an “overweight” rating in a report on Monday, January 6th. Bank of America upped their price target on Unum Group from $54.00 to $63.00 and gave the company a “neutral” rating in a report on Thursday, October 10th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $79.00 price target (up previously from $74.00) on shares of Unum Group in a report on Tuesday, January 7th. Piper Sandler lifted their price objective on shares of Unum Group from $74.00 to $82.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 18th. Finally, Morgan Stanley lifted their price objective on shares of Unum Group from $62.00 to $64.00 and gave the stock an “equal weight” rating in a research report on Wednesday, October 30th. Four investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, Unum Group has an average rating of “Moderate Buy” and an average target price of $79.00.

Insider Activity

In related news, CAO Walter Lynn Rice, Jr. sold 1,500 shares of the company’s stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $69.56, for a total value of $104,340.00. Following the completion of the sale, the chief accounting officer now directly owns 8,361 shares in the company, valued at approximately $581,591.16. This represents a 15.21 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Timothy Gerald Arnold sold 10,000 shares of the company’s stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $76.92, for a total transaction of $769,200.00. Following the completion of the sale, the executive vice president now owns 54,827 shares of the company’s stock, valued at $4,217,292.84. This represents a 15.43 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 102,914 shares of company stock worth $7,677,945 in the last ninety days. Corporate insiders own 0.93% of the company’s stock.

Unum Group Trading Down 1.0 %

Unum Group stock opened at $76.25 on Friday. The company’s fifty day simple moving average is $74.23 and its 200-day simple moving average is $64.52. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 0.32. Unum Group has a 12 month low of $46.39 and a 12 month high of $77.69. The stock has a market cap of $13.92 billion, a P/E ratio of 8.25, a P/E/G ratio of 1.09 and a beta of 0.81.

Unum Group (NYSE:UNM) last posted its quarterly earnings results on Tuesday, October 29th. The financial services provider reported $2.13 EPS for the quarter, beating the consensus estimate of $2.10 by $0.03. Unum Group had a net margin of 13.76% and a return on equity of 15.21%. The business had revenue of $3.22 billion for the quarter, compared to analysts’ expectations of $3.26 billion. During the same period in the previous year, the company posted $1.94 EPS. Unum Group’s revenue was up 4.0% on a year-over-year basis. As a group, sell-side analysts forecast that Unum Group will post 8.54 EPS for the current fiscal year.

Unum Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Friday, January 24th will be issued a dividend of $0.42 per share. This represents a $1.68 annualized dividend and a dividend yield of 2.20%. The ex-dividend date of this dividend is Friday, January 24th. Unum Group’s dividend payout ratio is currently 18.18%.

Unum Group Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.